Abstract
We read with interest the article entitled "Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?" by Aktas et al.1 The authors describe a 58-year-old man with ulcerative colitis who developed symmetrically distributed vitiligo facial patches around one week after receiving first dose of mRNA vaccine.1 the authors then ponder on the possible underlying immunological mechanism.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have